Department of endocrinology, Slagelse Hospiatl
Slagelse, 4200, Denmark
NCT Number: NCT04969159
Surgery induces insulin resistance lasting for 2-3 weeks. We wanted to elucidate if stress-metabolic, medical conditions carry the same effect.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Slagelse, 4200, Denmark
Background: Insulin resistance is well documented after surgery in a severity positively correlated to the degree of trauma (Thorell et al. 1999; Chambrier et al. 2000). Similar phenomena have been described in severely ill patients in ICU with consequences for the survival (Van den Berghe et al. 2001; The NICE-SUGAR Study Investigators 2009). The documentation, however, is scarce and the extent is unknown in acutely ill patients with sepsis.
Method: Adult, consecutive, non-diabetic patients with elevated CRP, leukocyte counts, SOFA-score of ≥ 2 were monitored with fasting p-C-peptide, blood glucose, CRP, leukocyte count and HOMA-IR at admittance, discharge and at two follow-up visits 2 weeks and 4 weeks after admission. Blood glucose levels were measured continuously during the whole study period with a flash glucose monitor mounted on the patients' upper arm. The diagnosis was sepsis, urosepsis, pneumonia, erysipecosis, bacteremia, infection with unknow focus and covid-19.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
standard treatment in the clinical routine
Time frame: 4 weeks
flash glucose monitor on the upper arm
Time frame: 4 weeks
plasma concentration
Time frame: 4 weeks
calculated glucose load test
Jens Rikardt Andersen
Other
Insulin Resistance in Septic Patients in the Acute Phase and After Discharge From Hospital
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06887439
Infections, Inflammation
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06727318
Acid-Base Imbalance, Acidosis
Ankara, KEÇİÖREN, Turkey (Türkiye)
View Trial DetailsNCT04580888
Disease Attributes, Echocardiography
Albi, France
View Trial DetailsNCT06181604
Infections, Inflammation
Boston, Massachusetts, United States
View Trial Details